Actively Recruiting
Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists
Led by Centre Hospitalier Emile Roux · Updated on 2025-07-30
664
Participants Needed
1
Research Sites
181 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.
CONDITIONS
Official Title
Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First consultation at the pain management center
- Chronic pain as defined by the Haute Autorité de Santé, with characteristics including persistence or recurrence, duration over 3 months, inadequate treatment response, and significant daily functional deterioration
- Diagnosis of chronic primary pain classified as chronic generalized pain, complex regional pain syndrome, chronic primary headache or orofacial pain, or chronic primary musculoskeletal pain
- Completion of the Pittsburgh Sleep Quality Index with score available for randomization
- Access to an internet connection for completing online questionnaires and online cognitive behavioral therapy if insomnia is detected
- Affiliation to a French social security system
- Provided free informed consent
You will not qualify if you...
- Receiving cancer treatment or completed cancer treatment within the last 2 years
- Having a chronic inflammatory disease such as rheumatoid arthritis, ankylosing spondylitis, chronic inflammatory bowel disease, Horton's disease, Wegener's disease, myositis, Still's disease, or lupus erythematosus
- Being immunocompromised
- Having severe psychiatric illness preventing study follow-up
- Already treated by a sleep specialist for a sleep disorder (hypnotic use alone does not exclude)
- Difficult follow-up due to geographic or other reasons
- Under judicial protection or guardianship
- Refusal to participate in the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Emile Roux
Le Puy-en-Velay, France
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here